Clinical trial of PAT-LM1 for the treatment of lymphomas

Trial Profile

Clinical trial of PAT-LM1 for the treatment of lymphomas

Planning
Phase of Trial: Phase I

Latest Information Update: 23 Apr 2014

At a glance

  • Drugs PAT LM1 (Primary)
  • Indications Lymphoma
  • Focus Adverse reactions
  • Most Recent Events

    • 23 Apr 2014 New trial record
    • 24 Mar 2014 Patrys has commenced the manufacturing process to produce PAT-LM1 for a future clinical trial, according to a company media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top